PhRMA Joins Fray In Gilead's 9th Circ. FCA Battle
Trade group Pharmaceutical Research and Manufacturers of America on Thursday pressed the Ninth Circuit to revisit its revival of a major False Claims Act suit targeting suspect manufacturing by Gilead Sciences...To view the full article, register now.
Already a subscriber? Click here to view full article